• Rigorous peer review
• Timely publishing
• No Article Processing Charges
The Journal of Current Oncology intends to cover all aspects of cancer biology, research, therapeutics and prevention. Some cancer therapies are also shifting from a tissue-specific focus to an oncogenetic pathway specific one. Developments in these new paradigms have a long way to go and it is a critical time for the field. Both patient volume and research in this field are increasing rapidly as are diagnostic and prognostic tests, targeted treatments and new practice patterns.
This Journal aspires to keep its readers abreast with high quality research work, scientific innovation, clinical Practice and surgical techniques using this open access platform. Articles are freely accessible online in perpetuity under a Creative Commons license. Issues from Vol 1, Issue 1 2018 to Vol 5, Issue 1, 2022 are available at https://www.journalofcurrentoncology.org/backissues.asp.
It is the official publication of Rajiv Gandhi Cancer Institute & Research Centre, a unit of Indraprastha Cancer Society & Research Center. It is a bi-annual journal meant for oncologists and medical professionals.
The Journal of Current Oncology is an open access, peer reviewed journal that aims to highlight the advances in Cancer Biology and management through an optimal mix of review articles, original research, case reports, letter to editors, resident pages and vignettes from frontline research. It is released biannually in an open access manner and goes through double- anonymized peer review process. It shall provide its contributors the benefit of review of their work by renowned experts and its reader with the authentic, well researched and reviewed information on all aspects of cancer.
Aims & Scope
1. To provide contemporary information in Oncology.
2. To highlight diverse spheres of Research in Oncology.
3. To provide young and experienced scientists / clinicians a platform to publish their research in a peer reviewed open access journal for worldwide readership.
4. To deliver solutions to multifaceted problems confronted routinely in the practice of oncology from screening to survivorship.
The Journal intends to cover all aspects of cancer biology, research, therapeutics and prevention. Some cancer therapies are also shifting from a tissue-specific focus to an oncogenetic pathway specific one. Developments in these new paradigms have a long way to go and it is a critical time for the field. Both patient volume and research in this field are increasing rapidly as are diagnostic and prognostic tests, targeted treatments and new practice patterns. It aspires to keep its readers abreast with high quality research work, scientific innovation, clinical Practice and surgical techniques using this open access platform.
|Anurag Mehta||Rajiv Gandhi Cancer Institute & Research Centre|
|Vineet Talwar||Rajiv Gandhi Cancer Institute & Research Centre|
|Swarupa Mitra||Rajiv Gandhi Cancer Institute & Research Centre|
|A K Chaturvedi||Rajiv Gandhi Cancer Institute & Research Centre|
|Sushila Kataria||Medanta-The Medicity Hospital|
|Gurudutt Gupta||Rajiv Gandhi Cancer Institute & Research Centre|
|Sudhir Rawal||Rajiv Gandhi Cancer Institute & Research Centre|
|D C Doval||Rajiv Gandhi Cancer Institute & Research Centre|
|N A Jambhekar||Tata Memorial Hospital|
|Patricia Bernal||University Hospital Fundacion Santa Fe de Bogota|
|Bharat Nathwani||City of Hope Comprehensive Cancer Center, Duarte, California, USA|
|Suash Sharma||Augusta University Health|
|Pavithran||Amrita Hospital, Kochi|
|Lalit Kumar||All India Institute of Medical Sciences|
|James Abraham||Cleveland Clinic|
|Govind Babu||Kidwai Memorial Institute of Oncology|
|Badrinath Konety||University of Minnesota|
|Kumar Prabhash||Tata Memorial Hospital|
|Vaishali Suri||All India Institute of Medical Sciences|
|Meenu Gupta||Swami Rama Himalayan University|
|Meenu Walia||Max Super Speciality Hospital, Patparganj|
|Reena Nair||Tata Medical Centre|
|Deepak Mishra||Tata Medical Centre|
|Mammen Chandy||Tata Medical Centre|
|Smreti Vasudevan||Rajiv Gandhi Cancer Institute & Research Centre|
|Alok Kumar||Rajiv Gandhi Cancer Institute & Research Centre|
|Shalini Agnihotri||Rajiv Gandhi Cancer Institute & Research Centre|
Journal of Current Oncology
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the journal’s submission site at https://peerreview.sagepub.com/coj to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of Journal of Current Oncology will be reviewed. As part of the submission will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere (either in full or in part; kindly refer to: https://publicationethics.org/case/salami-publication), and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Table of Contents:
1. Open Access
4.1 Peer review policy
4.5 Declaration of conflicting interests
4.6 Research ethics and patient consent
4.7 Clinical trials
4.8 Reporting guidelines
4.9 Research data
7.1 How to submit your manuscript
7.2 Title, keywords and abstract
7.3 Information required for completing your submission
7.5 Information required for completing your submission
Journal of Current Oncology (COJ) is an open access, peer-reviewed journal. Each article accepted following peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity.
For general information on open access at Sage please view our Open Access FAQs.
There is no article processing charge to publish in Journal of Current Oncology.
Before submitting your manuscript to Journal of Current Oncology, please ensure you have read the Aims & Scope.
Manuscripts can be submitted under various headings viz. Original Research, Review Articles, Perspectives/Commentary/Debate, Brief Communication, Case Reports/Case Series, Management Guidelines, Letter to Editor, Book Review, Film Review, Point of View, Obituary etc.
The Sage Author Gateway has some general advice and on how to get published, plus links to further resources. Sage Author Services also offers authors a variety of ways to improve and enhance their article including English language editing, plagiarism detection, and video abstract and infographic preparation.
For information and guidance on how to make your article our Gateway page on How to Help Readers Find Your Article Online.
Journal of Current Oncology adheres to a rigorous double-anonymized reviewing policy in which the identity of both the reviewer and author are always concealed from both parties.
Decisions on manuscripts will be taken as rapidly as possible. Authors should expect to have reviewer’s comments within approximately 8 weeks. In general, Editors will seek advice from two or more expert reviewers about the content and presentation of submitted articles.
All manuscripts are reviewed initially by the Editors and only those articles that meet the editorial standards of the journal, and fit within the aims and scope of the journal, will be sent for outside review.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor / Board member will have no involvement in the decision-making process to ensure that there is no ‘Conflict of Interest’.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This include all those who:
- Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
- Drafted the article or revised it critically for important intellectual content,
- Approved the version to be published,
- Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship as mentioned above.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
If the named authors for a manuscript change at any point between submission and acceptance, an Authorship Change Form must be completed and digitally signed by all authors (including any added or removed) . An addition of an author is only permitted following feedback raised during peer review. Completed forms can be uploaded at Revision Submission stage or emailed to the Journal Editorial Office contact (listed on the journal’s manuscript submission guidelines). All requests will be moderated by the Editor and/or Sage staff.
Important: Changes to the author by-line by adding or deleting authors are NOT permitted following acceptance of a paper.
Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.
All contributors who do not meet the criteria for authorship should be listed in the Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Please supply any personal acknowledgements separately to the main text to facilitate anonymous peer review.
Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:
- Disclose this type of editorial assistance – including the individual’s name, company and level of input
- Identify any entities that paid for this assistance
Where appropriate, Sage and COJ reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.
Individuals who provided assistance, e.g. , as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
Journal of Current Oncology requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the Sage Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of Journal of Current Oncology to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is/are no conflict(s) of interest’.
For guidance on conflict of interest statements, please see the ICMJE recommendations.
Medical research involving human subjects must be conducted according to the ICMR and World Medical Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the date of approval and the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
Journal of Current Oncology conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at MLM's Reasearch Reporting Guideline and Initiatives.
At Sage we are committed to facilitating openness, transparency and reproducibility of research. Where relevant, Journal of Current Oncology encourages authors to share their research data in a suitable public repository subject to ethical considerations and to include a data accessibility statement in their manuscript file. Authors should also follow data citation principles. For more information please visit the Sage Author Gateway, which includes information about Sage’s partnership with the data repository Figshare.
Sage is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and Committee on Publication Ethics (COPE) and to and view the Publication Ethics page on the Sage Author Gateway.
Journal of Current Oncology and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
If material has been previously published, it is not generally acceptable for publication in a Sage journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the Sage Author Gateway or if in doubt, contact the Editor at the address given below.
Before publication Sage requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Journal of Current Oncology publishes manuscripts under Creative Commons licenses. The standard license for the journal is Creative Commons by Attribution Non-Commercial (CC BY-NC), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit Sage's OA licenses page. Alternative license arrangements are available, for example, to meet particular funder mandates, made at the author’s request.
The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway
Illustrations, pictures and graphs, should be supplied in the highest quality and in an electronic format that helps us to publish your article in the best way possible. Please follow the guidelines below to enable us to prepare your artwork for the printed issue as well as the online version.
- Format: TIFF, JPEG: Common format for pictures (containing no text or graphs).
EPS: Preferred format for graphs and line art (retains quality when enlarging/zooming in).
- Placement: Figures/charts and tables created in MS Word should be included in the main text rather than at the end of the document.
Figures and other files created outside Word (i.e. Excel, PowerPoint, JPG, TIFF and EPS) should be submitted separately. Please add a placeholder note in the running text (i.e. “[insert Figure 1.]")
- Resolution: Rasterized based files (i.e. with .tiff or .jpeg extension) require a resolution of at least 300 dpi (dots per inch). Line art should be supplied with a minimum resolution of 800 dpi.
- Colour: Please note that images supplied in colour will be published in colour online and black and white in print (unless otherwise arranged). Therefore, it is important that you supply images that are comprehensible in black and white as well (i.e. by using colour with a distinctive pattern or dotted lines). The captions should reflect this by not using words indicating colour.
- Dimension: Check that the artworks supplied match or exceed the dimensions of the journal. Images cannot be scaled up after origination.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplemental files
Journal of Current Oncology adheres to the AMA Manual of Style. View the guide here to ensure your manuscript conforms to this style.
In a study by Smith et al,1 ….
Smith and Jones21 demonstrated that …
… according to studies12,14-17; in addition …
In the reference list, names of all the authors should be given unless there are more than 6, in which case the names of the first 3 authors should be used, followed by "et al."
Journal article (in print, published ahead of print):
Crews DW, Gartska WR, Meyer B, et al. The physiology of the garter snake: an analysis. Sci Am. 1981;245:158-159.
Armstrong DD. Rett syndrome neuropathology review [published online May 3, 2001]. Brain Dev. doi:10.1002/CD1023.
Voet D, Voet JG. The Science of Biochemistry. 3rd ed. New York, NY: J Wiley; 1990.
Chapter in a book:
Kuret JA, Murad F. Adenohypophyseal hormones. In: Gilman AG, Taylor P, eds. The Pharmacological Basis of Therapeutics. 8th ed. Orlando, FL: Grune & Stratton; 1976:1334-1360.
Paper presented at a conference:
Eisenberg J. Market forces and physician workforce reform: why they may not work. Paper presented at: Annual Meeting of the Association of American Medical Colleges; October 28, 1995; Washington, DC.
Blackburn TA. Updating autologous chondrocyte implantation knee rehabilitation. Orthopedic Tech Review. 2003;5:30-33. http://www.orthopedictechreview.com/issues/julaug03/pg30.htm. Accessed January 7, 2005.
Websites: FDA resources page. Food and Drug Administration website http://vm.cfsan.fda.gov/sodium.txt. Accessed June 23, 2000.
Journal of Current Oncology is hosted on Sage Track Sage, a web-based online submission and peer review system. Visit https://peerreview.sagepub.com/coj to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created.
Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the Sage Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online.
Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
As part of our commitment to ensuring an ethical, transparent and fair peer review process Sage is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID IDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. The affiliation listed on the manuscript should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
Please ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the Sage Author Gateway
If your paper is accepted for publication after peer review, you will first be asked to complete the contributor’s publishing agreement. Thereafter the manuscript is sent ahead for production process and subsequently published online.
Your Sage Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will made available to the corresponding author by email to the corresponding author and should be returned promptly in the time-period so specified. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate.
One of the many benefits of publishing your research in an open access journal is the speed to publication. With no page count constraints, your article will be published online in a fully citable form with a DOI number as soon as it has completed the production process. At this time it will be completely free to view and download for all.
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The Sage Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, Sage is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximize your article’s impact with Kudos.
Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the Journal of Current Oncology editorial office as follows:
The Editor, Journal of Current Oncology